Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ezekowitz

Showing results (761-770 of 842) with videos related to

Pageof 85
Sort By:
Stroke|May 3, 2014
Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline for healthcare professionals from the American Heart Association/American Stroke AssociationWalter N Kernan, Bruce Ovbiagele, Henry R Black, et al.
Scientific Reports|June 24, 2022
Clinical risk, sociodemographic factors, and SARS-CoV-2 infection over time in Ontario, CanadaJacob A Udell, Bahar Behrouzi, Atul Sivaswamy, et al.
European Journal of Heart Failure|October 17, 2022
Soluble guanylate cyclase stimulators in patients with heart failure with reduced ejection fraction across the risk spectrumJaved Butler, Muhammad Shariq Usman, Kevin J Anstrom, et al.
Circulation. Heart Failure|June 3, 2022
Vericiguat and Health-Related Quality of Life in Patients With Heart Failure With Reduced Ejection Fraction: Insights From the VICTORIA TrialJaved Butler, Amanda Stebbins, Vojtěch Melenovský, et al.
The American Journal of Geriatric Cardiology|June 21, 2001
Executive Summary: Pivotal Research in Cardiovascular Syndromes in the ElderlyCharles R. McKay, Michael W. Rich, Ronald E. Vlietstra, et al.
The Canadian Journal of Cardiology|January 23, 2008
Canadian Cardiovascular Society Consensus Conference guidelines on heart failure--2008 update: best practices for the transition of care of heart failure patients, and the recognition, investigation and treatment of cardiomyopathiesJ Malcom, O Arnold, Jonathan G Howlett, et al.
Heart Rhythm O2|January 2, 2023
Residual stroke risk despite oral anticoagulation in patients with atrial fibrillationMatthew A Carlisle, Peter Shrader, Marat Fudim, et al.
Lancet (London, England)|October 6, 2012
Efficacy and safety of apixaban compared with warfarin according to patient risk of stroke and of bleeding in atrial fibrillation: a secondary analysis of a randomised controlled trialRenato D Lopes, Sana M Al-Khatib, Lars Wallentin, et al.
American Heart Journal|May 27, 2019
Treatment of atrial fibrillation with concomitant coronary or peripheral artery disease: Results from the outcomes registry for better informed treatment of atrial fibrillation IITaku Inohara, Peter Shrader, Karen Pieper, et al.
Lancet (London, England)|December 5, 2016
Chronic Oral Study of Myosin Activation to Increase Contractility in Heart Failure (COSMIC-HF): a phase 2, pharmacokinetic, randomised, placebo-controlled trialJohn R Teerlink, G Michael Felker, John J V McMurray, et al.
Pageof 85

Showing results (761-770 of 842) with videos related to

Sort By:
Pageof 85
Stroke|May 3, 2014
Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline for healthcare professionals from the American Heart Association/American Stroke AssociationWalter N Kernan, Bruce Ovbiagele, Henry R Black, et al.
Scientific Reports|June 24, 2022
Clinical risk, sociodemographic factors, and SARS-CoV-2 infection over time in Ontario, CanadaJacob A Udell, Bahar Behrouzi, Atul Sivaswamy, et al.
European Journal of Heart Failure|October 17, 2022
Soluble guanylate cyclase stimulators in patients with heart failure with reduced ejection fraction across the risk spectrumJaved Butler, Muhammad Shariq Usman, Kevin J Anstrom, et al.
Circulation. Heart Failure|June 3, 2022
Vericiguat and Health-Related Quality of Life in Patients With Heart Failure With Reduced Ejection Fraction: Insights From the VICTORIA TrialJaved Butler, Amanda Stebbins, Vojtěch Melenovský, et al.
The American Journal of Geriatric Cardiology|June 21, 2001
Executive Summary: Pivotal Research in Cardiovascular Syndromes in the ElderlyCharles R. McKay, Michael W. Rich, Ronald E. Vlietstra, et al.
The Canadian Journal of Cardiology|January 23, 2008
Canadian Cardiovascular Society Consensus Conference guidelines on heart failure--2008 update: best practices for the transition of care of heart failure patients, and the recognition, investigation and treatment of cardiomyopathiesJ Malcom, O Arnold, Jonathan G Howlett, et al.
Heart Rhythm O2|January 2, 2023
Residual stroke risk despite oral anticoagulation in patients with atrial fibrillationMatthew A Carlisle, Peter Shrader, Marat Fudim, et al.
Lancet (London, England)|October 6, 2012
Efficacy and safety of apixaban compared with warfarin according to patient risk of stroke and of bleeding in atrial fibrillation: a secondary analysis of a randomised controlled trialRenato D Lopes, Sana M Al-Khatib, Lars Wallentin, et al.
American Heart Journal|May 27, 2019
Treatment of atrial fibrillation with concomitant coronary or peripheral artery disease: Results from the outcomes registry for better informed treatment of atrial fibrillation IITaku Inohara, Peter Shrader, Karen Pieper, et al.
Lancet (London, England)|December 5, 2016
Chronic Oral Study of Myosin Activation to Increase Contractility in Heart Failure (COSMIC-HF): a phase 2, pharmacokinetic, randomised, placebo-controlled trialJohn R Teerlink, G Michael Felker, John J V McMurray, et al.
Pageof 85